It has been found that IGF2 in low dose acts through IGF2R and alleviates colitis via promoting anti-inflammatory macrophages, suggesting that IGF2 family strongly controls generation of anti-inflammatory macrophages and may provide novel strategies for the treatment of inflammatory diseases [34]. This evidence concerns the gene IGF2R and colitis.